Cannabis vapor triggers concerning cell growth changes in lungs via hidden pathway

This study examines how cannabis vapor affects human lung cells, focusing on a previously overlooked molecular target called the aryl hydrocarbon receptor (AhR). Researchers exposed lung epithelial cells to vaporized cannabis containing approximately 2 μg of THC and compared normal cells to cells lacking AhR. The key finding is that cannabis vapor promotes abnormal cell growth through AhR activation, a mechanism distinct from the well-known cannabinoid receptor pathways. When cells lacked AhR, this growth-promoting effect disappeared, suggesting AhR is essential for the respiratory system's response to cannabis vapor.

Beyond simple gene activation, the study reveals that AhR orchestrates complex changes at multiple biological levels, including turning on genes associated with cell cycle progression and altering how genetic information is processed through alternative splicing. These sophisticated molecular changes occurred in normal cells but not in AhR-deficient cells, indicating AhR acts as a central controller coordinating the epithelial response to cannabis vapor. The findings suggest a potential connection between cannabis vaping and oncogenic signaling pathways, meaning the molecular changes triggered could theoretically promote cancer-like cell behavior.

For cannabis users and public health, this research highlights an important concern: vaping cannabis may be less harmful than smoking, but it still triggers concerning molecular responses in lung tissue. The discovery of AhR's role opens new questions about long-term respiratory health impacts and suggests that cannabis safety discussions should consider targets beyond traditional cannabinoid receptors. Future research will be crucial to determine whether these laboratory findings translate to real health risks in actual users.